XML 53 R36.htm IDEA: XBRL DOCUMENT v3.22.0.1
Equity (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of reconciliation of common stock share activity

(Shares of common stock, in thousands)

Issued

Held in Treasury

Outstanding

 

Balance at December 31, 2018

77,811

11,285

66,526

Issuance of restricted stock units as compensation

(105)

105

Performance shares and other share-based awards

(5)

5

Stock options exercised

(182)

182

Purchase/acquisition of treasury stock

Balance at December 31, 2019

77,811

10,993

66,818

Issuance of restricted stock units as compensation

(69)

69

Performance shares and other share-based awards

(5)

5

Stock options exercised

(124)

124

Purchase/acquisition of treasury stock

Balance at December 31, 2020

77,811

10,795

67,016

Issuance of restricted stock units as compensation

(69)

69

Performance shares and other share-based awards

(6)

6

Stock options exercised

(331)

331

Purchase/acquisition of treasury stock

765

(765)

Balance at December 31, 2021

77,811

11,154

66,657

Schedule of stock based compensation expense

(in millions)

 

2021

    

2020

    

2019

 

Stock options:

Pre-tax compensation expense

$

3

 

$

4

 

$

3

Income tax benefit

 

 

 

Stock option expense, net of income taxes

 

3

 

4

 

3

Restricted stock units ("RSUs"):

Pre-tax compensation expense

 

12

 

12

 

10

Income tax benefit

 

(1)

 

(1)

 

(2)

RSUs, net of income taxes

 

11

 

11

 

8

Performance shares and other share-based awards:

Pre-tax compensation expense

 

8

 

7

 

5

Income tax benefit

 

(1)

 

(1)

 

Performance shares and other share-based compensation expense, net of income taxes

 

7

 

6

 

5

Total share-based compensation:

Pre-tax compensation expense

 

23

 

23

 

18

Income tax benefit

 

(2)

 

(2)

 

(2)

Total share-based compensation expense, net of income taxes

$

21

 

$

21

 

$

16

Schedule of valuation assumptions for stock options

For the Year Ended December 31,

2021

2020

2019

Expected life (in years)

5.5

5.5

5.5

Risk-free interest rate

 

0.6

%  

1.4

%  

2.5

%

Expected volatility

23.2

%  

19.8

%  

19.7

%

Expected dividend yield

2.9

%  

2.9

%  

2.7

%

Schedule of stock option transactions

    

Number of Options (in thousands)

    

Weighted Average Exercise Price per Share

    

Average Remaining Contractual Term (Years)

    

Aggregate Intrinsic Value (in millions)

 

Outstanding as of December 31, 2020

 

2,238

$

86.55

 

5.15

 

$

14

Granted

 

358

87.12

Exercised

 

(331)

62.05

Cancelled

 

(111)

91.39

Outstanding as of December 31, 2021

 

2,154

$

90.39

 

5.26

 

$

26

Exercisable as of December 31, 2021

 

1,591

$

91.21

 

4.09

 

$

21

Schedule of additional information pertaining to stock option activity

Year Ended December 31, 

(dollars in millions, except per share)

  

2021

    

2020

2019

Weighted average grant date fair value of stock options granted (per share)

$

12.31

$

11.48

$

14.02

Total intrinsic value of stock options exercised

10

5

10

Summary of net changes in accumulated other comprehensive loss

(in millions)

    

Cumulative Translation Adjustment

    

Hedging Activities

    

Pension and Postretirement Adjustment

    

AOCL

   

Balance, December 31, 2018

$

(1,080)

(5)

(69)

(1,154)

Other comprehensive (loss) income before reclassification adjustments

(9)

(19)

11

(17)

Amount reclassified from accumulated OCL

14

14

Tax benefit (provision)

1

(2)

(1)

Net other comprehensive (loss) income

(9)

(4)

9

(4)

Balance, December 31, 2019

(1,089)

(9)

(60)

(1,158)

Other comprehensive (loss) income before reclassification adjustments

(25)

5

(2)

(22)

Amount reclassified from accumulated OCL

65

65

Tax (provision) benefit

(19)

1

(18)

Net other comprehensive (loss) income

(25)

51

(1)

25

Balance, December 31, 2020

$

(1,114)

$

42

$

(61)

$

(1,133)

Other comprehensive (loss) gain before reclassification adjustments

(100)

218

28

146

Loss (gain) reclassified from accumulated OCL

311

(209)

102

Tax (provision)

(3)

(9)

(12)

Net other comprehensive income

211

6

19

236

Balance, December 31, 2021

$

(903)

$

48

$

(42)

$

(897)

Schedule of basic and diluted earnings per common share

2021

2020

2019

Net Income

Weighted

Per

Net Income

Weighted

Per

Net Income

Weighted

Per

Available

Average

Share

Available

Average

Share

Available

Average

Share

(in millions, except per share amounts)

    

to Ingredion

  

Shares

  

Amount

  

to Ingredion

  

Shares

  

Amount

  

to Ingredion

  

Shares

  

Amount

Basic EPS

$

117

 

67.1

$

1.74

$

348

 

67.2

$

5.18

$

413

 

66.9

$

6.17

Effect of Dilutive Securities:

Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards

 

0.7

 

0.4

 

0.5

Diluted EPS

$

117

 

67.8

$

1.73

$

348

 

67.6

$

5.15

$

413

 

67.4

$

6.13

RSU | Employee  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of restricted unit activity

Weighted

Number of

Average

Restricted

Fair Value

(shares in thousands)

Shares

per Share

Non-vested at December 31, 2020

418

$

96.45

Granted

239

87.79

Vested

(95)

121.80

Cancelled

(76)

89.52

Non-vested at December 31, 2021

486

$

88.34